Pressure Biosciences Inc 's ability to collect accounts receivable sequentially worsen to 7.4, indicating more challenging environment then in the first quarter 2024, but still, it is a far cry from any concerns. Pressure Biosciences Inc 's Accounts Receivable average collection period in the Jun 30 2024 quarter, has increased to 49 days, from 47 days, in the Mar 31 2024 quarter.

If we take a look into Healthcare sector 98 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1030, from overall ranking in the first quarter 2024 at 1219.

What is Receivable Turnover Ratio?
What is Pressure Biosciences Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PBIO Receivables Turnover Ratio	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	-2.66 %	-63.12 %	-48.8 %	98 %	-40.34 %
Y / Y Revenue Change	-17.59 %	-52.84 %	-48.56 %	186.74 %	2.74 %
Receivable Turnover Ratio (TTM)	7.4	7.79	7.45	7.54	7.69
PBIO's Total Ranking	# 1030	# 1219	# 1216	# 1402	#
Accounts Receivable average collection period days	49	47	49	48	47
Seq. Receivable Change	27.2 %	-4.36 %	-54.07 %	74.22 %	-51.8 %
Seq. Revenue Change	20.77 %	11.82 %	-24.37 %	-19.3 %	-30.89 %

Receivable Turnover Company Ranking
Within:	No.
Laboratory Analytical Instruments Industry	# 2
Healthcare Sector	# 99
Overall Market	# 1030

Receivable Turnover Ratio Statistics
High	Average	Low
11.15	5.47	2.4
(Jun 30 2024)		(Dec 31 2020)

PBIO Company Profile • Back to PBIO Efficiency Comparisons • Compare PBIO Receivables Turnover Ratio to its Competitors

Financial Statements
Pressure Biosciences Inc 's Accounts Receivable	$ 0 Millions	Visit PBIO's Balance sheet
Pressure Biosciences Inc 's Sales TTM	$ 1 Millions	Visit PBIO's Income Statement
Sources of PBIO's Revenues		Visit PBIO's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PBIO's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PBIO's Growth Rates	PBIO's Roa	PBIO's Inventory Turnover Ratio	PBIO's Dividend Comparisons
PBIO's Profitability Ratios	PBIO's Roi	PBIO's Asset Turnover Ratio	PBIO's Dividend Growth
PBIO's Valuation Ratios	PBIO's Roe	PBIO's Financial Strength Ratios	PBIO's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2024	Receivable at quarter ending Jun 30 2024
Kiniksa Pharmaceuticals International Plc	22.32	$ 338.930 Millions	$ 15.188 Millions
U S Physical Therapy Inc	22.07	$ 627.673 Millions	$ 28.444 Millions
Cytomx Therapeutics Inc	21.94	$ 119.569 Millions	$ 5.451 Millions
Vireo Growth Inc.	21.79	$ 98.044 Millions	$ 4.500 Millions
Bespoke Extracts Inc	21.65	$ 1.047 Millions	$ 0.048 Millions
Inmed Pharmaceuticals Inc	20.51	$ 5.331 Millions	$ 0.260 Millions
Editas Medicine Inc	20.47	$ 67.033 Millions	$ 3.275 Millions
Neuraxis Inc	20.46	$ 2.267 Millions	$ 0.111 Millions
Dih Holding Us Inc	19.47	$ 112.297 Millions	$ 5.769 Millions
Innovage Holding Corp	19.06	$ 763.855 Millions	$ 40.068 Millions
Arcellx Inc	18.39	$ 144.745 Millions	$ 7.870 Millions
Innovative Eyewear Inc	18.25	$ 1.530 Millions	$ 0.084 Millions
Hookipa Pharma inc	18.18	$ 52.163 Millions	$ 2.870 Millions
Ginkgo Bioworks Holdings Inc	17.78	$ 184.335 Millions	$ 10.367 Millions
Recursion Pharmaceuticals Inc	17.44	$ 49.635 Millions	$ 2.846 Millions
Co diagnostics Inc	17.27	$ 9.137 Millions	$ 0.529 Millions
Medinotec Inc	17.25	$ 6.931 Millions	$ 0.402 Millions
Milestone Scientific Inc	17.23	$ 8.408 Millions	$ 0.488 Millions
Scynexis Inc	17.22	$ 9.666 Millions	$ 0.561 Millions
Talkspace Inc	16.80	$ 171.081 Millions	$ 10.184 Millions
Lineage Cell Therapeutics Inc	16.62	$ 6.186 Millions	$ 0.372 Millions
Jrsis Health Care Corp	16.36	$ 4.516 Millions	$ 0.276 Millions
Neuroone Medical Technologies Corp	16.24	$ 3.922 Millions	$ 0.242 Millions
Stablecoin Development Corporation	15.69	$ 11.596 Millions	$ 0.739 Millions
Scorpius Holdings inc	15.48	$ 9.845 Millions	$ 0.636 Millions
Qhslab Inc	15.46	$ 1.613 Millions	$ 0.104 Millions
Pulmatrix Inc	15.32	$ 11.392 Millions	$ 0.744 Millions
Nutriband Inc	15.31	$ 1.804 Millions	$ 0.118 Millions
Nexalin Technology Inc	15.30	$ 0.150 Millions	$ 0.010 Millions
Wave Life Sciences Ltd	15.05	$ 110.500 Millions	$ 7.344 Millions

Date modified: 2026-09-08T15:11:29+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.